ストックスクリーナーアプリを入手
0.83
4.40%
0.035
アフターアワーズ：
.80
-0.03
-3.61%
前日終値:
$0.795
開ける：
$0.81
24時間の取引高:
4.20M
Relative Volume:
12.11
時価総額：
$925.37K
収益：
-
当期純損益:
$-9.34M
株価収益率:
-0.0914
EPS:
-9.0833
ネットキャッシュフロー:
$-6.69M
1週間 パフォーマンス:
-12.63%
1か月 パフォーマンス:
-58.95%
6か月 パフォーマンス:
-92.48%
1年 パフォーマンス:
-96.52%
1日の値動き範囲:
$0.721
$0.8829
1週間の範囲:
$0.721
$1.03
52週間の値動き範囲:
$0.721
$23.71
Painreform Ltd Stock (PRFX) Company Profile
Painreform Ltd (PRFX) 最新ニュース
Navigating PRFX’s Stock Market Maze: Ups and Downs in 2023 - The InvestChronicle
Financial Health Check: Examining PainReform Ltd (PRFX)’s Key Ratios - The Dwinnex
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.23% - MSN
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.23% - MSN
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.23% - MSN
PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110 - GlobeNewswire
PainReform Ltd. Launches Warrant Exercise Incentive Program - TipRanks
PainReform confirms sutures compatibility for in trial for PRF-110 - TipRanks
PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110 - StockTitan
Ratio Analysis: Unpacking PainReform Ltd (PRFX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
PainReform to issue new warrants in stock exercise deal By Investing.com - Investing.com Australia
PainReform Shares Are Trading Lower Today: What's Going On - Benzinga
PRFX stock touches 52-week low at $1.17 amid steep annual decline - Investing.com
PRFX stock touches 52-week low at $1.17 amid steep annual decline - Investing.com UK
PainReform to issue new warrants in stock exercise deal - Investing.com
PainReform to issue new warrants in stock exercise deal By Investing.com - Investing.com Canada
PainReform to issue new warrants in stock exercise deal By Investing.com - Investing.com UK
PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds - GlobeNewswire
PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds - StockTitan
Holdings of PainReform Ltd (PRFX) are aligned with the stars - SETE News
PainReform Ltd [PRFX] is -90.64% lower this YTD. Is it still time to buy? - The DBT News
Upcoming Stock Splits This Week (September 9 to September 13) – Stay InvestingTHE BHARAT EXPRESS NEWS - The Bharat Express News
PainReform Ltd: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - The InvestChronicle
PainReform Ltd (PRFX) stock analysis: A simple moving average approach - US Post News
PainReform Ltd’s Mixed Bag: Down -90.20% in 6 Months, Down -38.34% in 30 Days - The InvestChronicle
PainReform Announces Reverse Share Split - TipRanks
Market Momentum: PainReform Ltd (PRFX) Registers a -4.21 Decrease, Closing at 0.22 - The Dwinnex
PainReform (NASDAQ:PRFX) Shares Down 11.7% - Defense World
PRFX stock touches 52-week low at $0.24 amid sharp annual decline - Investing.com
Market Insight: PainReform Ltd (PRFX)’s Notable Gain, Closing at 0.27 - The Dwinnex
The time has not yet come to remove your chips from the table: PainReform Ltd (PRFX) - SETE News
PainReform Ltd. Schedules 2024 Annual Meeting - TipRanks
Do investors need to be concerned about PainReform Ltd (PRFX)? - US Post News
Prepare Yourself for Liftoff: PainReform Ltd (PRFX) - SETE News
PainReform reports breakthrough in post-surgical pain management - Investing.com India
PainReform reports breakthrough in post-surgical pain management - Investing.com
PainReform Bunionectomy Study Observations Confirm Optimal Delivery Method for PRF-110 in Bunionectomy Procedures - Yahoo Finance
PainReform Bunionectomy Study Observations Confirm Optimal - GlobeNewswire
Ratios Reveal: Breaking Down PainReform Ltd (PRFX)’s Financial Health - The Dwinnex
PainReform reports safety data from Phase III bunionectomy trial of PRF-110 - Yahoo Finance
PRFX stock touches 52-week low at $0.28 amid sharp annual decline - Investing.com India
PainReform reports positive early safety data in Phase 3 study - Investing.com India
PainReform Ltd: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - The InvestChronicle
PainReform reports positive early safety data in Phase 3 study - Investing.com
PRFX stock touches 52-week low at $0.28 amid sharp annual decline - Investing.com
PRFX stock touches 52-week low at $0.28 amid sharp annual decline - Investing.com Canada
PRFX stock touches 52-week low at $0.28 amid sharp annual decline - Investing.com Australia
PRFX stock touches 52-week low at $0.28 amid sharp annual decline - Investing.com UK
PRFX Stock Earnings: PainReform Beats EPS for Q2 2024 - MSN
PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study - GlobeNewswire
PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study - StockTitan
Painreform Ltd (PRFX) 財務データ
収益
当期純利益
現金流量
EPS
2.46%
0.55%
大文字化:
|
ボリューム (24 時間):